SEED Therapeutics

China Clears IND for SEED Therapeutics’ First-in-Class Cancer Drug in Global Trial Push

KING OF PRUSSIA, PA — SEED Therapeutics announced that China’s National Medical Products Administration has cleared the Investigational New Drug application for ST-01156, enabling Chinese sites to participate in the …

China Clears IND for SEED Therapeutics’ First-in-Class Cancer Drug in Global Trial Push Read More